Geron Stock Today
| GERN Stock | USD 3.73 0.05 1.36% |
Performance9 of 100
| Odds Of DistressLess than 10
|
Geron is selling at 3.73 as of the 19th of April 2024; that is 1.36% increase since the beginning of the trading day. The stock's open price was 3.68. Geron has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Geron are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. The company was incorporated in 1990 and is headquartered in Foster City, California. The company has 588.06 M outstanding shares of which 46.66 M shares are currently shorted by private and institutional investors with about 2.48 trading days to cover. More on Geron
Moving against Geron Stock
| 0.62 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
| 0.46 | EWTX | Edgewise Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.42 | KZR | Kezar Life Sciences Financial Report 9th of May 2024 | PairCorr |
Follow Valuation Odds of Bankruptcy
Financial Report 9th of May 2024
Geron Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Geron's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Geron or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | John Scarlett |
| Thematic Idea | Cancer Fighters (View all Themes) |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Cancer Fighters, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
| Financial Strength Based on the analysis of Geron's profitability, liquidity, and operating efficiency, Geron is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Geron is based on its profitability, leverage, liquidity, source of funds, and operating efficiency. | |
Geron (GERN) is traded on NASDAQ Exchange in USA. It is located in 919 East Hillsdale Boulevard, Foster City, CA, United States, 94404 and employs 141 people. Geron is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.11 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Geron's market, we take the total number of its shares issued and multiply it by Geron's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Geron conducts business under Biotechnology sector and is part of Health Care industry. The entity has 588.06 M outstanding shares of which 46.66 M shares are currently shorted by private and institutional investors with about 2.48 trading days to cover.
Geron currently holds about 219.29 M in cash with (167.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58.
Check Geron Probability Of Bankruptcy
Ownership AllocationGeron secures a total of 588.06 Million outstanding shares. Over half of Geron's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Geron. Please watch out for any change in the institutional holdings of Geron as this could mean something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Geron Ownership Details
Geron Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Geron jumping above the current price in 90 days from now is nearly 4.87%. The Geron probability density function shows the probability of Geron stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Geron has a beta of -4.3393. This usually indicates as returns on its benchmark rise, returns on holding Geron are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Geron is expected to outperform its benchmark. Moreover, geron has an alpha of 1.7472, implying that it can generate a 1.75 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Geron to move above the current price in 90 days from now is nearly 4.87 (This Geron probability density function shows the probability of Geron Stock to fall within a particular range of prices over 90 days) .
Geron Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Geron market risk premium is the additional return an investor will receive from holding Geron long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Geron. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Geron's alpha and beta are two of the key measurements used to evaluate Geron's performance over the market, the standard measures of volatility play an important role as well.
| Risk Adjusted Performance | 0.0833 | |||
| Jensen Alpha | 1.75 | |||
| Total Risk Alpha | 0.2989 | |||
| Sortino Ratio | 0.2654 |
Geron Stock Against Markets
Picking the right benchmark for Geron stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Geron stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Geron is critical whether you are bullish or bearish towards Geron at a given time. Please also check how Geron's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Geron without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Geron Corporate Directors
Geron corporate directors refer to members of a Geron board of directors. The board of directors generally takes responsibility for the Geron's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Geron's board members must vote for the resolution. The Geron board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Dawn Bir | Independent Director | Profile | |
| Karin Eastham | Independent Director | Profile | |
| Elizabeth OFarrell | Independent Director | Profile | |
| Daniel Bradbury | Independent Director | Profile |
How to buy Geron Stock?
Before investing in Geron, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Geron. To buy Geron stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Geron. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Geron stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Geron stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Geron stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Geron, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Geron Stock please use our How to Invest in Geron guide.
Already Invested in Geron?
The danger of trading Geron is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Geron is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Geron. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Geron is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Geron offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Geron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Geron Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Geron Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Geron Stock analysis
When running Geron's price analysis, check to measure Geron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Geron is operating at the current time. Most of Geron's value examination focuses on studying past and present price action to predict the probability of Geron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Geron's price. Additionally, you may evaluate how the addition of Geron to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges |
Is Geron's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.